These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
720 related articles for article (PubMed ID: 10428963)
1. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963 [TBL] [Abstract][Full Text] [Related]
2. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400 [TBL] [Abstract][Full Text] [Related]
3. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650 [TBL] [Abstract][Full Text] [Related]
4. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498 [TBL] [Abstract][Full Text] [Related]
5. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227 [TBL] [Abstract][Full Text] [Related]
6. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931 [TBL] [Abstract][Full Text] [Related]
7. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572 [TBL] [Abstract][Full Text] [Related]
8. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992 [TBL] [Abstract][Full Text] [Related]
9. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cell recognition of HLA class I molecules. Brooks AG; Boyington JC; Sun PD Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
12. The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules. López-Botet M; Carretero M; Pérez-Villar J; Bellón T; Llano M; Navarro F Immunol Res; 1997; 16(2):175-85. PubMed ID: 9212363 [TBL] [Abstract][Full Text] [Related]
13. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449 [TBL] [Abstract][Full Text] [Related]
14. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923 [TBL] [Abstract][Full Text] [Related]
15. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253 [TBL] [Abstract][Full Text] [Related]
16. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Boyington JC; Riaz AN; Patamawenu A; Coligan JE; Brooks AG; Sun PD Immunity; 1999 Jan; 10(1):75-82. PubMed ID: 10023772 [TBL] [Abstract][Full Text] [Related]
17. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076 [TBL] [Abstract][Full Text] [Related]
18. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors. O'Callaghan CA Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639 [TBL] [Abstract][Full Text] [Related]
20. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. Kaiser BK; Barahmand-Pour F; Paulsene W; Medley S; Geraghty DE; Strong RK J Immunol; 2005 Mar; 174(5):2878-84. PubMed ID: 15728498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]